Pathstone Holdings
PCVX icon

Pathstone Holdings’s Vaxcyte PCVX Stock Holding History

Pathstone Holdings’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Buy
27,166
+2,937
+12% +$159K 0.01% 1151
2025
Q4 		$1.12M Buy
24,229
+2,140
+10% +$95.7K ﹤0.01% 1351
2025
Q3 		$796K Buy
22,089
+1,459
+7% +$48.3K ﹤0.01% 1547
2025
Q2 		$671K Sell
20,630
-2,117
-9% -$69.4K ﹤0.01% 1580
2025
Q1 		$859K Sell
22,747
-8,794
-28% -$703K ﹤0.01% 1461
2024
Q4 		$2.58M Buy
31,541
+1,014
+3% +$101K 0.01% 842
2024
Q3 		$3.49M Buy
30,527
+2,154
+8% +$194K 0.02% 694
2024
Q2 		$2.14M Buy
28,373
+5,100
+22% +$347K 0.01% 896
2024
Q1 		$1.59M Buy
23,273
+19,516
+519% +$1.35M 0.01% 1026
2023
Q4 		$236K Buy
+3,757
New +$195K ﹤0.01% 1974

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return